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ABSTRACT  
Aims: Understanding the spatiotemporal dynamics of reactive cell types following brain 
injury is important for future therapeutic interventions. We have previously used penetrating 
cortical injuries following intracranial recordings as a brain repair model to study scar-
forming nestin-expressing cells. We now explore the relationship between nestin-expressing 
cells, PDGFRβ+ pericytes and Olig2+ glia, including their proliferation and functional 
maturation.  
Methods: In 32 cases, ranging from 3 to 461 days post injury (dpi), immunohistochemistry 
for PDGFRβ, nestin, GFAP, Olig2, MCM2, Aquaporin 4 (Aq4), Glutamine Synthetase (GS), 
and Connexin 43 (Cx43) were quantified for cell densities, labelling index (LI) and cellular 
co-expression at the injury site compared to control regions.  
Results: PDGFRβ labelling highlighted both pericytes and multipolar parenchymal cells. 
PDGFRβ LI and PDGFRβ+/MCM2+ cells significantly increased in injury zones at 10-13 dpi 
with migration of pericytes away from vessels with increased co-localisation of PDGRFβ 
with nestin compared to control regions (p < 0.005). Olig2+/MCM2+ cell populations peaked 
at 13 dpi with significantly higher cell densities at injury sites than in control regions (p < 
0.01) and decreasing with dpi (p < 0.05). Cx43 LI was reduced in acute injuries but increased 
with dpi (p < 0.05) showing significant cellular co-localisation with nestin and GFAP 
(p<0.005 and p<0.0001) but not PDGFRβ.  
Conclusions: These findings indicate that PDGFRβ+ and Olig2+ cells contribute to the 
proliferative fraction following penetrating brain injuries, with evidence of pericyte 
migration. Dynamic changes in Cx43 in glial cell types with dpi suggests functional 
alterations during temporal stages of brain repair. 
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Introduction  
There is a fine balance in repair processes following brain injury between the beneficial 
effects that limit tissue damage and restore homeostasis and the long-term detrimental effects 
that can follow glial scar formation, such as impediment to axonal regeneration and increased 
risk of seizures [1, 2]. Understanding which endogenous progenitor cell types contribute to 
tissue reorganisation after brain injury, and the mechanisms that regulate their differentiation 
and functional maturation, are essential for any therapeutic interventions targeting this 
process. 
Most studies of the spatio-temporal progression of glial and vascular alterations have been 
carried out using experimental animal models of brain injury [2-4] and are dependent on the 
type of model used and, together with inter-species differences, are not always translatable to 
human brain injury. Studies investigating brain repair in human tissues have largely been 
dependent on post-mortem material with its inherent limitations. We have previously 
overcome this by utilising surgical specimens with penetrating cortical injuries following 
intracranial recordings (ICR) carried out for the pre-operative investigation of epilepsy [5, 6]. 
As the time interval between initial electrode placement and subsequent tissue resection is 
precisely known (but variable between cases) and the injury is localised, this provides a 
unique spectrum from acute injuries to chronic scars, spanning from 3 days to over 1-year old 
injuries, to study spatiotemporal processes in human brain repair. Our previous studies 
identified that, in addition to microglia, nestin-expressing cells represent a highly 
proliferative cell type at the acute injury site, often elongated with a close relationship to 
vessels and remaining in chronic scars; a proportion of these nestin-expressing cells were 
immunopositive for GFAP [5]. In experimental injury models, functionally distinct subtypes 
of astroglia are recognised, regulating inflammatory responses and repair, including specific 
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‘scar-forming astrocytes’ with elongated processes [3, 7]. The source of proliferating and 
scar-forming glia in injuries is not fully established. Progenitor cell types in the adult brain, 
including oligodendroglial progenitor cells (OPCs), NG-2 cells as well as resident 
parenchymal nestin-expressing glia with proliferative capacity [8], are candidates. A further 
possibility, particularly in view of the observed intimate relationship of new capillaries and 
glia in the repair process, is that nestin-expressing cells are recruited from progenitors in the 
perivascular niche, including pericytes with capacity for neuroectodermal differentiation [9].   
Pericytes form an essential part of the neurovascular unit, responsible for regulating the 
capillary blood flow through controlling capillary structure and diameter, promoting the 
development and maintenance of the blood-brain barrier, and controlling the proliferation, 
migration and stabilisation of endothelial cells [10-13]. Pericytes may be divided into 
different subtypes based on their function, morphology, location and expression of 
immunohistochemical markers including platelet-derived growth factor receptor beta 
(PDGFRβ), alpha smooth muscle actin (α-SMA), chondroitin sulfate proteoglycan (NG2), 
regulator of G protein signalling (RGS-5), and the potassium channel Kir6.1 [14-16]; they 
have also been reported to express nestin  in neonatal and adult rat brain cultures [17, 18]. 
PDGFRβ expressing pericytes have been proposed to be an important source of endogenous 
progenitor cells [9, 13, 19, 20], capable of enhanced proliferation following injury in 
experimental models [10, 18, 21]. However, a recent study showed that Tbx18+ pericytes did 
not behave as stem cells, including following brain injury and repair [22], highlighting an 
ongoing controversy in this area.  
As reactive glial progenitors proliferate and differentiate following injury to form the chronic 
scar, the temporal expression of functional markers, for example those involved in glio-
transmission, could be relevant to any local cellular dysfunction as well as epileptogenesis 
[23]. Cx43 is the main gap junction protein in astrocytes, establishing homeostatic cell 
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communication [24]. Cx43 hemichannels also mediate ‘gliotransmission’ of bioactive 
molecules [25, 26] and astroglial connexins and Aquaporin 4 are implicated in spreading 
depolarisation that can follow brain injury [27, 28]. Glutamate synthetase, while integral to 
normal glial glutamate metabolism and excitatory neuronal transmission, is deficient in glial 
progenitor types [29].  
Using our series of ICR injury cases we hypothesised that (i) OPC, and PDGFRβ expressing 
pericytes contribute to the proliferative cell types following focal injury, (ii) their 
spatiotemporal distribution, morphology and dynamics are closely related to GFAP-negative 
nestin-expressing cells and (iii) that relative differences in markers of functional maturation 
between reactive glial populations over the time course of brain repair could be observed.  
 
Materials and methods 
The project has ethical approval and written informed consent was obtained from all patients. 
 
Case selection 
Surgical brain specimens from 32 patients, with pharmacoresistant focal epilepsy, who had 
placement of subdural and/or depth electrodes during pre-operative intracranial EEG 
recordings at various periods prior to resective surgery between 2002 to 2015, were included 
in the study. All samples were received through the Epilepsy Society Brain and Tissue Bank 
at the Department of Neuropathology, UCL Queen Square Institute of Neurology. The lesion 
age in each case was recorded as days post injury (dpi; interval between the placement of the 
electrodes and tissue resection) which ranged from 3 to 461 days. Cases were also arbitrarily 
grouped into four temporal stages of cellular injury and repair for qualitative analyses and to 
enable comparison with our previous studies [5]: acute (3-9 dpi; n=6), subacute (10-13 dpi; 
n=7), intermediate (28-70 dpi; n=5) and chronic lesions (107-461dpi; n=14). The clinical 
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details of the cases are presented in Table 1; 19 cases were male and the mean age at surgery 
was 36 years (range, 18 to 60 years). The injury types involved the superficial cortex 
including the sub-pial layer (following subdural grid placements; n=14) or were needle-like 
track penetrating injuries (from depth electrode insertion; n=19) (Table 1). Most tissue 
resections were from the frontal (n=17) and temporal (n=12) lobes. In 13 cases, no distinct 
pathology was identified in the resection (non-lesional); the remaining cases showed focal 
cortical dysplasia (FCD) type IIB (n=10), FCD IIID (n=1), hippocampal sclerosis (n=3), low-
grade epilepsy-associated tumour (LEAT) (n=4) and a focal scar from traumatic brain injury 
(n=1). In all cases except one (case E22), the ICR lesion was not located in the same area as 
the main pathology. 
 
Immunohistochemical and double-label immunofluorescence studies 
Five-micron thick serial sections were cut from each block bearing the injury; one was 
stained with Haematoxylin and Eosin as a reference for the location of the ICR lesion as well 
as to delineate the anatomical boundaries of three zones: lesion core and margins (Zone 1 and 
2) and control region. Further serial sections were used in single and double labelled 
chromogenic and immunofluorescence studies. The protocols and methods used were as 
published in previous studies [5, 8] (Supplementary methods). Antibodies used in single or 
double labelled studies included glial/glial progenitor markers, nestin, GFAP, Olig2; 
pericyte markers PDGFRβ [13, 21] and SMA; proliferative cell marker, MCM2, and 
functional glial markers, Glutamine synthetase (GS), Aquaporin4 (Aq4) and astrocyte gap 
junction protein Connexin 43 (Cx43) (Supplementary Table). It was not possible to include 
every case in all immunohistochemical and immunofluorescence studies as ICR lesions were 
small, and some were ‘cut-out’ in serial sections. However, for each study, a comparable 
number of cases from each of the four time periods were included (detailed in Table 1).  
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Quantitative analyses 
The distribution and morphology of single and double labelled cell types were visualised 
using Nikon brightfield microscope, Zeiss Axio Imager Z2 motorized fluorescence 
microscope, and LSM700 confocal microscope (Zeiss, Oberkochen, Germany), and 
compared between differing zones, age of lesions, and the temporal stages of brain repair.  
PDGFRβ, nestin, GFAP, and Cx43 double-labelled immunofluorescent sections: Each 
immunolabelled slide was tiled using a 20x objective and regions of interest drawn as 
described in previous studies [5] using Zen imaging software (Carl Zeiss Microscopy, Jena, 
Germany). Zone 1 refers to the margin of the ICR lesion, the internal border formed by the 
medial edge of viable tissue to a radial depth of 350 µm, forming a circumferential region 
surrounding the injury site (Figure 1a, b). The precise shapes and size of zones drawn varied 
between cases, according to the contours of the ICR injury. Zone 2 represented tissue of 
equal radial depth marginal to Zone 1 (qualitative evaluation only), and Zone 3 was a control 
region of 2000 µm2 located as far away from the ICR injury site as possible within normal-
appearing tissue in the same tissue section. Care was taken to select a comparable region of 
control white matter or grey matter according to the ICR lesion site. Fluorescent signal 
thresholds were set for each fluorochrome using the Zen imaging software and were kept 
consistent across cases. For each set of double labelling studies, the labelling index (LI), 
rather than cell numbers, was measured since most markers labelled abundant cell processes 
in the brain parenchyma. In addition, the relative area of co-localisation (RAC; the area of co-
labelling/total area of Zone 1 or Zone 3) and co-localisation coefficients were calculated 
including Pearson’s and Mander’s coefficients as measures of the degree of co-localisation, 
where 1 indicates perfect overlap of signal, -1 indicates a negative correlation and 0 indicates 
random overlap [30]. A proportion of cases were re-tested between two observers with good 
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reproducibly (intra-class correlation coefficient 0.995). For Olig2/MCM2 sections, the same 
procedure for acquisition of the zones was performed, but the number of double-labelled cells 
per area was manually counted. 
MCM2/PDGFRβ double labelled chromogenic sections: Slides were scanned with a Leica 
SCN400F digital slide scanner (Leica Microsystems, Wetzlar, Germany) at 40x 
magnification, and immunolabelling in the same regions of interests as described above was 
analysed using the automated image analysis software, Definiens Tissue Studio software 3.6 
(Definiens AG, Munich, Germany). Double-labelled cells were automatically counted as 
MCM2+ brown nuclear labelling (MCM2) when surrounded by PDGFRβ+ cytoplasmic 
purple labelling, and the data was expressed as the number of cells per area.   
GS, Aq4 and Cx43 single labelling: Serial images were manually captured at 40x 
magnification from three regions of interest: zone 0 (injury core), zone 1 (organising edge of 
the lesion) and zone 3. Immunolabelling was thresholded using ImageProPlus (v6.3; 
MediaCybernetics, Bethesda, MD, USA), and the LI for each area calculated.  
Statistical analyses were performed using SPSS for windows version 21 (IBM corporation, 
version 21), and significance between groups was taken at P<0.05. Tests included Kruskal–
Wallis non-parametric tests with post-hoc correction for multiple comparisons and Wilcoxon 
signed rank to compare cases between different zones. Spearman’s correlation and regression 
analysis were used to explore the relationships between labelling and dpi. 
 
In vitro scratch assay 
To investigate the response to injury after 24 hours, a scratch assay was performed on cells 
cultured from a gram of freshly resected brain tissue of two surgical patients with focal 
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epilepsy (Cases EC1, EC2; Table 1) and the proportion, morphology and spatial distribution 
of nestin-expressing cells incorporating EdU A was quantified (see supplemental methods). 
 
RESULTS 
 
Pericytes and glial cell reactions in ICR injuries 
Qualitative analysis Nestin/PDGFRβ: In acute ICR lesions, multipolar nestin+ cells and 
nestin+ cells with elongated processes became prominent between capillaries in Zone 1 and 2 
(Figure 2A-C); in Zone 3, nestin labelling was noted mainly in capillaries (Figure 2J). In 
subacute to intermediate ICR lesions, there was greater prominence of nestin+ cells between 
new capillaries in both Zones 1 and 2 (Figure 1D, 2D-G). In chronic ICR lesions, dense 
meshworks of nestin+ fibres persisted in Zone 1 around vessels at the scar site (Figure 2H, I) 
as previously described [5]. PDGFRβ in acute lesions showed focal expression in pericyte-
like cells around capillaries in Zones 1 and 2 at 3 dpi (Figure 2A). By 8-9 dpi, increased 
numbers of PDGFRβ+ bipolar cells and processes were present around capillaries (Figure 2 
B, C arrows), and by 13 dpi forming lace-like meshworks extending away from capillaries, 
becoming more prominent in intermediate-aged lesions (Figure 1C-F 2D-F). In addition, in 
Zones 2 and 3, smaller multipolar PDGFRβ+ glial-like cells not associated with capillaries 
were identified (Figure 2J-L). In chronic lesions and oldest scars, PDGFRβ expression at the 
scar site became limited to perivascular pericytes (Figure 2H). Co-localisation of nestin with 
PDGFRβ was noted around acute, subacute and intermediate lesions in a proportion of the 
elongated cells in proximity to capillaries in Zone 1 (Figure 2C, D). In addition, the lace-like 
processes extending between capillaries in Zone 1 (Figure 2D-F) and multipolar cells in Zone 
2 and 3 also showed focal co-expression (Figure 2J-L). The small multipolar PDGFRβ cells, 
however, were not SMA positive, with PDGFRβ/SMA co-expression restricted to pericyte-
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like cells (Figure 2M-P). GFAP/PDGFRβ: At low power, GFAP+ cells and processes formed 
a clear band of labelling at the boundary of Zone 1 and 2 in subacute injuries, mainly 
peripheral to an inner region of PDGFRβ+ cells and new capillaries, forming distinct 
compartments at low power (Figure 1E). At higher magnification in Zone 1 of acute to 
chronic lesions, although many GFAP+ reactive processes appeared separate from PDGFRβ 
(Figure 3B to E), intermingling and overlapping of processes with focal co-localisation was 
noted (Figure 3F, G). GFAP and PDGFRβ+ cells also appeared relatively distinct in Zone 3. 
MCM2: PDGFRβ+/MCM2+ pericytes were prominent in subacute lesions in the immediate 
vicinity of capillaries and also in the elongated cells extending out from and between small 
capillaries (Figure 1C, 4A). Small Olig2+ cells with nuclear MCM2 co-expression (Figure 
4C, D), indicating replicative potential, were also prominent in the ICR lesion site compared 
to normal cortex. The overall morphology of Olig2+ cells did not alter with dpi, although 
labelling was restricted to the nucleus. 
Quantitative analysis: Nestin, PDGFRβ, GFAP. Nestin and PDGFRβ LI were significantly 
higher in Zone 1 (injury region) than Zone 3 (control region) in all cases (p<0.001), but 
GFAP LI was not different (p=0.526) (Table 2). There was a significant regression of nestin 
expression with dpi in Zone 1 (p<0.04; Figure 3A) but not in Zone 3 (Supplemental Figure 
2A), nor for GFAP or PDGFRβ. There was a significant correlation between nestin and 
PDGFRβ LI for all cases in Zone 1 (p<0.001) but not with GFAP. There was a significantly 
greater relative area of co-localisation of nestin/PDGFRβ (p=0.003) and GFAP/PDGFRβ in 
Zone 1 than Zone 3 (p = 0.02) in all ICR lesions over the time stages (Table 2; Supplemental 
Figure 2B) and the Pearson correlation coefficient for co-localisation for nestin/PDGFRβ was 
significantly higher than for GFAP/PDGFRβ (p=0.047, Wilcoxon test). There was a trend for 
increased co-localisation between GFAP/PDGFRβ and decreased nestin/PDGFRβ with dpi, 
but this was not significant.  
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MCM2: There was a significant increase in MCM2/PDGFRβ+ cell density in Zone 1 
compared to Zone 3 (p<0.005); mean densities peaked in the subacute lesions in Zone 1 
(Table 2) but there was no significant correlation of MCM2/PDGFRβ+ cells with dpi in either 
zone. The density of Olig2/MCM2+ cells was significantly higher in Zone 1 than Zone 3 
(p=0.006); their number peaked at 13 dpi in subacute lesions with densities ten times higher 
than in normal regions (Table 2). By 28 dpi, the density of MCM2/Olig2+ cells had markedly 
decreased and continued to fall in chronic lesions to levels comparable with normal regions, 
with a significant regression shown with dpi in Zone 1 (Figure 4E; exponential p=0.028). In 
vitro scratch assay: The responses of proliferative cell populations 24 hours following injury 
were further explored in vitro, since tissue samples with 1 dpi lesions were rarely available. 
33% of the cells cultured from resected samples from two patients with focal epilepsy 
incorporated EdU A 24 hours after the scratch. 10% of proliferative EdU A incorporated cells 
also expressed nestin (Figure 4F). The majority of EdU A/nestin+ cells showed unipolar or 
bipolar morphology and did not appear to be apoptotic. These cells were found up to 7000 
m away from the induced lesion site. More EdU A labelled cells seem to be located further 
away from the scratch border than at the lesion site (Figure 4G).  
 
Functional glial maturation in ICR injuries 
 
Qualitative Cx43: In the control regions (Zone 3), diffuse labelling of astrocyte-like cells was 
present in the cortex (Figure 5F) and in glial cells mainly around vessels in the white matter. 
In acute ICR injuries, loss of Cx43 was apparent in the core of the ICR lesions, forming a 
sharply demarcated boundary with the adjacent parenchyma (Figure 1F, 5A); 
immunoreactivity at later stages was noted in relation to capillary endothelium (Figure 5B). 
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By 8-9 dpi, Cx43 expression in the injury margin was observed in elongated cells around 
vessels and from subacute to intermediate lesions, Cx43 immunopositivity in the 
endothelium, pericyte cells and reactive multipolar cells became more evident (Figure 5C, 
D). In chronic lesions, the central necrotic core had contracted with intense labelling of 
Cx43+ processes demarcating the ICR scar site (Figure 5E). Aq4: In control regions (Zone 3), 
dense labelling of glial processes in both cortex and white matter was apparent, particularly 
in foot processes around blood vessels (Figure 5J). In acute ICR lesions, the loss of Aq4 
immunolabelling in the injury site formed a well-defined boundary, separating this area from 
the retained Aq4 immunolabelling in the adjacent viable tissue (Figure 5H), including 
labelling of reactive cells (Zone 1) (Figure 5I). GS: Expression was predominantly observed 
in the perinuclear cytoplasm of small glial cells in control regions (Figure 5M). GS+ cells 
with reactive astrocytic morphology were present in subacute and intermediate ICR lesions 
Zone 1 (Figure 5K) and more intensely labelled GS+ cells in older lesions (Figure 5L). Cx43 
with nestin/GFAP: Striking membranous Cx43 expression in large, reactive nestin and 
GFAP positive cells was observed in acute and subacute ICR injuries in Zone 1 (Figure 6A, 
B). In both subacute (Figure 6D, E) and intermediate lesions (Figure 6 G, H) co-expression of 
both nestin and GFAP with Cx43 was noted in a proportion of processes at the organising 
margin, particularly around vessels. In chronic injuries, GFAP showed a more complete co-
overlap with Cx43 (Figure 6K) than nestin (Figure 6J). In addition, large reactive Cx43+ cells 
were noted, negative for both nestin (Figure 6G) and GFAP (Figure 6H). Cx43 labelling of 
endothelium was also noted. In chronic injuries, and Zone 3, the majority of GFAP reactive 
cells showed Cx43 labelling (Figure 6M). Cx43/PDGFRβ: In acute and subacute lesions, 
there was very occasional co-expression in pericytes around capillaries in the organising 
margin of Zone 1 (Figure 6C, F). Overall, there was less evidence for co-expression 
compared to nestin and GFAP, a more distinct pattern being Cx43+ endothelium and 
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surrounding PDGFRβ-positive pericytes in organising vessels (Figure 1F, insert). Large 
Cx43+ reactive cells were typically PDGFRβ negative (Figure 6I) and minimal co-
localisation was observed in chronic scars (Figure 6L). In Zone 3, separate distribution of 
PDGFRβ and Cx43 was appreciated (Figure 6N); however, occasional co-localisation in 
small multipolar cells between vessels was observed (Figure 6N, inset). 
Quantitative Cx43: Significant differences were noted in Cx43 LI for all injuries between 
injury core and control region (Zone 3) (p<0.005) (Table 2) with a significant linear increase 
in Cx43 in Zone 0 with dpi (p=0.03) (Figure 5G). Aq4: There was significantly lower Aq4 LI 
in the lesion core (Zone 0) in all injuries compared to Zone 3 (p<0.001) (Table 2) but no 
significant correlation of Aq4 LI with dpi. GS: There were no statistically significant 
differences in LI between zones or correlation with dpi (Table 2). 
Double labelling quantitation: For Cx43/nestin, there was a significant increase in the 
relative area of co-localisation comparing between Zone 1 and 3 (p=0.038) (Table 2); this 
was not noted for Cx43/GFAP. There was a significant linear increase in relative area of co-
localisation for both Cx43/nestin and Cx43/GFAP with dpi (p=0.002 and p<0.0001) (Figure 
6O). No statistical differences were noted for Cx43/PDGFRβ co-localisation either between 
zones or with dpi (Figure 6O). 
 
DISCUSSION 
 
Using ICR penetrating injuries in human tissues, we investigated the spatiotemporal 
dynamics of PDGFRβ+ cells and its relationship with other glial cell types such as GFAP and 
nestin expressing cells in the formation of a glial scar. Several morphological types of 
PDGFRβ+ cells were observed in lesional and perilesional tissue. PDGFRβ+ pericyte cells as 
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well as Olig2+ glia contribute to the proliferating cell fraction in acute and subacute injury 
sites, in addition to the nestin+ cells and Iba1+ cells as previously described [5] . PDGFRβ+ 
pericyte cells also extended away from vessels in the active organising injuries, showed focal 
nestin expression, but diminished in chronic lesions. Furthermore, the relative differences and 
dynamic changes of Cx43 gap protein expression in glio-vascular and reactive cell types is of 
potential relevance to functional changes following penetrating brain injury. Together with 
data from our previous study [5] we can formulate the cellular spatiotemporal dynamics in 
brain repair in human tissues (Supplemental Figure 3).  
Needle tracks following intracranial electrode insertion provide a specific model for 
penetrating brain injury, without superimposed rotational or ischaemic injury, and with the 
advantage that injuries of a precise age can be studied in optimally fixed surgical tissues. In 
our previous study, nestin + cells were prominent replicative cell types in ICR injuries with 
close relationship to vessels and remained in the chronic scar [5]. In the present study, using 
in vitro scratch assay on primary cell cultures, proliferative nestin expressing cells were seen 
as early as 24 hours after injury. Most of these cells have morphology similar to immature 
migrating cells. These findings are in line with observations in animal models of injury [7, 
31, 32]. However, the source of the nestin+ scar forming glial cells is unexplained and we 
speculated on their relationship to pericytes, which we further investigated in this current 
study. 
PDGFRβ+ pericyte migration and proliferation in injuries 
PDGFRβ is widely recognised as a reliable marker of CNS pericytes under normal conditions 
[9, 13, 21]. Around the ICR injury, a significant increase in PDGFRβ+ pericytes was observed 
compared to control regions, with a close spatial and temporal relationship to nestin+ cells, 
sharing similarities in cell morphology and distribution, including elongated, bipolar cell 
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forms in proximity to new vessels. PDGFRB+ pericyte cells also extended away from 
capillary walls at the injury margin. Pericyte migration or ‘lifting’ away from micro-vessels 
has been previously shown using electron microscopy in models of traumatic brain injury 
(TBI) at 2 days following injury [33], with loss of their contact with the blood vessels, 
invasion through the vascular basement membrane [34] and PDGFRβ+ pericyte ‘detachment’ 
[21]. In tissues from patients with acute strokes, increased numbers of ramified pericyte cells 
bridging between vessels has also been reported [35]. Using MCM2 co-labelling, we also 
demonstrated increased replicative potential of PDGFRβ+ pericytes as well as in the detached 
cells, that peaked at 8 to 13 dpi (subacute stage). In spinal cord and brain injury models, 
proliferation of type 1 pericytes was shown 14 days after injury [36] and proliferation of 
PDGFRβ+ cells demonstrated with Ki67 labelling in ischaemic stroke lesions [35] as well as 
cortical models of TBI [37].  
Evidence for the contribution of pericytes to glial scar formation 
Experimental TBI studies mainly focus on the earlier stages of repair and have demonstrated 
a quantitative increase in PDGFRβ+ cells and mRNA from 3-5 dpi [37] and 2 to 7 dpi [21]. 
The density of PDGFRβ+ cells has been shown to diminish by 14 dpi [36] and by 3 months 
post injury, only perivascular pericytes were reported in the glial scar [21], but still with 
elevated numbers at 7 months compared to those before injury in another study [34]. In the 
current study with chronic injuries of over 15 months, PDGFRβ expression was restricted 
mainly to perivascular cells at the scar site. In contrast, although nestin labelling overall 
diminished with dpi, nestin+ cells and processes remained, demarcating the chronic scar. A 
strong relationship between the LI of PDGFRβ and nestin across all stages of injuries was 
shown and co-labelling identified nestin+/PDGFRβ-, nestin-/PDGFRβ+ and nestin+/PDGFRβ+ 
cells in organising injuries. In our previous study, we reported increased co-localisation 
between nestin and GFAP with dpi [5] and in the current study we noted a trend for a 
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decreased relative area of co-localisation of PDGFRβ with nestin with dpi but an increase in 
co-expression with GFAP.  
Although these temporal changes could reflect heterogeneous reactive cell populations during 
repair process (i.e. augmented nestin expression in PDGFRβ+ pericytes or transient PDGFRβ+ 
expression in nestin+ glia), an alternative explanation is that following pericyte proliferation 
and migration, a subset differentiate to scar-forming glial cells  [19, 34, 36]. In spinal cord 
injury models, ablation of NG2+ pericyte cells reduced GFAP density in the glial scar [38]. In 
a further study, genetic ablation of pericytes led to failure to seal the scar, implicating 
pericytes as a probable source of scar-forming cells [34]. Recent studies have demonstrated 
that the application of a PDGFR inhibitor disrupted glial scar formation following injury [39].  
In experimental systems and TBI models, cellular co-expression of PDGFRβ and GFAP in 
reactive cells has been shown in some [13, 19, 21, 39] but not all studies [34, 37]. In a recent 
lineage-tracing experiment, Tbx18-expressing pericytes did not co-localise with GFAP-
astrocytes following injury [22]. In the present study, there were rare, overlapping 
PDGFRβ+/GFAP+ processes located close to the ICR lesions. A more striking qualitative 
observation in this study, however, was the ‘zonality’ or relative compartmentalisation in the 
ICR injuries, with reactive PDGFRβ+ pericytes and nestin+ cells forming the inner border of 
the organising scar with a surrounding rim of predominantly GFAP+ reactive glia. Such 
‘layering’ of organising scars has been previously noted in experimental models [34, 38] as 
well as in human strokes where PDGFRβ+ proliferating cells were demarcated from the 
surrounding astrocytic gliosis [35]. The findings of the present study therefore support two 
components to brain repair: the formation of a central, chronic, contracted glial scar, 
dependent on early proliferation and then decline of PDGFRβ+ and nestin+ cell types and an 
outer predominantly GFAP+ glial scar.  
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PDGFRβ+ CNS parenchymal cells 
There is accumulating evidence that PDGFRβ is also expressed in resting brain parenchymal 
cells other than pericytes. We previously reported, in the white matter of adult epilepsy cases 
with FCD, small multipolar cells, away from capillaries, which co-expressed PDGFRβ and 
PDGFRα as well as NG2 and likely represented subsets of NG2 progenitor glia [40]. An 
increase in ramified PDGFRβ+ parenchymal cells was observed in human temporal lobe 
epilepsy (TLE) that co-localised with NG2 but not Iba1 [41] and their redistribution shown 
following experimental status, suggesting they are reactive populations [42]. Kyyriainen et 
al., recently described PDGFRβ+ cells with small soma and ramified processes in normal 
mice brain, shown to be either PDGFRα+ or GFAP+ and dynamic changes in their distribution 
was also shown following both experimental status and trauma. [21]. In the present study, 
small PDGFRβ+ parenchymal cells were more evident away from the injury site in normal 
white matter and their focal co-expression with nestin and, to lesser extent GFAP, was shown 
but not SMA, supporting their distinction from pericytes. We cannot exclude that pre-existing 
parenchymal PDGFRβ+ glia also contribute to reactive, proliferating populations at injury 
sites.  
Oligodendrocyte lineage progenitors (OPCs) are in close apposition with pericytes in the 
perivascular space, with evidence for mutual interactions, promoting proliferation [43]. 
Surgical TBI resections have shown an increase in OPC number at injury site [44] and 
transient proliferation of OPC noted between 7 to 21 dpi in a diffuse TBI model [45]. In our 
study significant proliferation was confirmed, with Olig2/MCM2+ cells peaking at 13 dpi 
then falling to control levels in chronic lesions. The morphology of Olig2/MCM2+ remained 
‘oligo-like’ with no definite evidence of glial/pericyte maturation; however, no double 
labelling of Olig2 with nestin or PDGFR was performed in the present study. We have also 
recently identified nestin+ radial glial cell types in adult temporal lobe with regenerative 
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capacity, glial maturation in vitro and focal co-localisation with PDGFRβ [8]. Heterogeneous 
populations of regenerative parenchymal cells could therefore potentially contribute to 
astroglial scar formation following injury. Further work is needed to define their cellular 
interactions and signalling pathways that are pivotal to optimal brain repair. 
Connexin43 and functional glial markers  
Expression of astroglial markers Cx43, Aq4 and GS in reactive cell types is further evidence 
of their differentiation, and also reflects functional alterations over the time course of brain 
repair, of potential relevance to epileptogenesis and other post-traumatic sequela [23]. Cx43 
is the main gap junction protein in astrocytes [24] and Cx43 hemi-channels, mediating 
‘gliotransmission’ and release of bioactive molecules from astrocytes [25, 26]. Both 
connexins and Aq4 are implicated in spreading depolarisation following injury [27, 28]. 
Connexins are also critical to cell-cell interactions and establishing homeostatic cell 
communication following injury [46], driving cell reactivity [3] and promoting neuronal 
recovery [47] ; for example, the extent of gliosis is larger in Cx43 KO mice [48] . 
We noted spatio-temporal alterations in expression, with initial reduction at the injury site for 
Cx43 and Aq4 labelling compared to control regions but increased labelling of Cx43 with dpi 
and its cellular co-expression with GFAP (see summary Supplemental Figure 3). In 
experimental TBI models, an initial decrease in Cx43 was also reported followed by an 
increase from 6 to 15 dpi [48]. We noted only occasional co-localisation of Cx43 with 
perivascular PDGFRβ+ pericytes but exaggerated endothelial labelling; loss of Cx43 in 
pericytes has been linked to functional decline and vascular instability [49] and increased 
endothelial expression with defective blood brain barrier [50]. Dynamic changes in Cx43 
expression in the neurovascular unit in brain repair warrant further investigation regarding 
physiological versus detrimental role.   
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Limitations 
All of the patients had refractory focal epilepsy and it is likely that seizures influence the 
baseline glial populations, including densities of nestin [8], PDGFR+ glial cells [41, 42] and 
Cx43 expression on astrocytes [24] in zone 3 used as the control region as in previous 
studies.  Nevertheless, we favoured this as optimal control tissue over post-mortem tissue 
with agonal changes and delayed and longer fixation times which could affect staining. 
 
In summary, in the ICR brain injury model we have identified that (i) PDGFRβ+ and Olig2+ 
cells contribute to the proliferative fraction with evidence of pericyte migration away from 
the vessels into the organising scar, (ii) the formation of a glial scar is composed of two 
zones, the central zone enriched in nestin+ pericytes and an outer zone of reactive GFAP 
astrocytes, (iii) PDGFRβ also identifies populations of small neuroglial cells and (iv) glial 
differential markers,  as  Cx43, show altered distribution in reactive cells and the 
neurovascular unit during repair which could have functional implications. 
ACKNOWLEDGEMENTS AND FUNDING 
This work is supported by a grant from the MRC MR/J0127OX/1. This work was undertaken 
at UCLH/UCL, which received a proportion of funding from the Department of Health’s 
NIHR Biomedical Research Centres funding scheme. Epilepsy Society, through the Katy 
Baggott Foundation, supports the UCL Epilepsy Brain and Tissue Bank. JL was supported by 
EPITARGET. All authors have no conflicts of interest to declare. We are grateful to Matthew 
Ellis for his help with image analysis using the Definiens system and also to Joanna Goc for 
the preparation of some of the material used in this study.  
STATEMENT OF AUTHOR CONTRIBUTION 
JL, CR and APJ were involved in the section preparation and analysis. MT was involved in 
data collection and study design. JL and MT conducted all the data analysis and 
interpretation. JL, CR and MT were involved in manuscript preparation. SS conceived the 
initial injury study design and reviewed the manuscript.  
20 
 
 
 
Figures and Legends 
Figure 1: Intracranial recording (ICR) injury at low power.  
A. A subacute lesion (13 days post injury) involving the cortical surface which represents one 
of the larger foci of injury in the series. H&E section highlighting the main regions used for 
qualitative evaluation and delineation of the Zones for study. The Necrotic core (Zone 0) 
contains mainly non-viable material and macrophages. Zone 1 is the rim of viable material 
surrounding the core and contains reactive cells and vessels and Zone 2 surrounds Zone 1. B. 
The same section showing the superimposed measured Zone 1 with a width of 350 microns 
which was tiled for image analysis. C. PDGFRβ chromogenic stained section (purple) with 
MCM2 labelling of nuclei (brown, visible in inset) in the same case to highlight the labelling 
in Zone 1 of vessels and in D. with immunofluorescent labelling for PDGFRβ with nestin 
highlighting capillaries and reactive glial cells in Zone 1. E. GFAP with PDGFRβ shows the 
relative compartmentalisation of labelling at low power with the majority of GFAP positivity 
external to the PDGFRβ. F. Cx43 with PDGFR β at low power and shown in the inset at 
higher magnification, with a close relationship between PDGFRB pericytes surrounding 
Cx43-positive endothelium. Higher magnifications for C are shown in Figure 4, D in Figure 
2, E in Figure 3 and F in Figure 6. Bar is 700 microns. 
 
Figure 2: Pericytes and nestin-expressing reactive glial cell types in intracranial 
recording (ICR) injuries of different stages  
A-C: Nestin/PDGFRβ in acute injuries in zone 1. A. At three days post injury (dpi) nestin 
labelling was relatively confined to vessel endothelium and PDGFRβ in pericytes, forming an 
incomplete layer around the endothelium. B-C. At 8 to 9 dpi, increased nestin expression in 
perivascular, reactive and bipolar stromal cells (arrows) with increased PDGFRβ cells around 
small vessels (chevrons), some with focal nestin co-expression (arrowhead; asterisks indicate 
capillary lumen); In C the nestin and PDGFRβ are shown as single channels. D, E. 
Nestin/PDGFRβ in subacute injuries in zone 1. D. At this stage nestin expression is noted 
in elongated processes and reactive, bipolar and multipolar cells between capillaries and co-
expression with PDGFRβ is observed (arrowhead; split channel images shown in 
supplemental figure 1). E. ‘Lace-like’ proliferations of PDGFRβ+ cells lifting away from the 
vasculature (asterisk) is noted (chevrons) (split channels shown in supplemental figure 1). F. 
Nestin/PDGFRβ in intermediate age injuries in zone 1. By this stage more prominent 
increase in the number and networks of PDGFRβ+ cells in zone one is noted, not associated 
with vessels (asterisk) and with some focal nestin co-expression (split channels shown in 
supplemental Figure 2); these cells declined in number with age and, in G. shown at 52 dpi, 
PDGFRβ expression is more limited to vasculature (asterisk). H. and I. Nestin/PDGFRβ in 
chronic injuries in zone 1 at 209 and 301 dpi respectively, show a residual increase in 
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nestin+ fibrous processes, demarcating the scar site whereas PDGFRβ expression is mainly 
perivascular. J. Nestin/PDGFRβ in acute injuries in zone 3 in acute (8 dpi) and 
intermediate phases (K. 28dpi and L. 52 dpi) show multipolar cells that are nestin+ (arrow), 
PDGFRβ+ (chevron) or show double-labelling (arrowhead) (asterisks indicate capillary) (J to 
L : shown at higher magnification in supplemental Figure 1C’). M to P. SMA/PDGFRβ 
double labelling in zone 1 confirms co-localisation in pericytic cells surrounding capillaries 
(arrowheads) but not in small multipolar PDGBRβ+ cells (arrows). In all figures, asterisks 
denote capillary vascular channels, arrowheads double labelled cells and arrows and chevrons 
single labelled cells as indicated. Scale bar shown in P is equivalent to 500 microns in A-G, 
1000 and 20 microns in J to P. 
 
 
Figure 3 Pericytes and GFAP-expressing reactive glial cell types in intracranial 
recording (ICR) injuries of different stages 
A. Scatter graphs of labelling index of nestin, PDGFRβ and GFAP plotted against dpi 
(expressed as log10); only nestin showed a significant regression with the age of the lesion. 
GFAP/PDGFRβ in zone 1:  B (acute), D (subacute), C (intermediate) and E (chronic) 
stages. The necrotic core of the penetrating injury is highlighted with yellow asterisk. 
Increased numbers of GFAP+ fibres and PDGFRβ expressing cells are intermingled but form 
distinct populations at low magnification. Shown at higher magnification in F (subacute) and 
G (chronic, same case as E) shows approximation with intermingled and overlapping 
networks of GFAP and PDGFRβ processes in zone 1 with apparent co-localisation in single 
processes (arrowheads Figure G) although orthogonal views were not available. Scale bar 
shown in G equivalent to 100 microns in B to E and 50 microns in F and G. 
 
Figure 4.  
A. MCM2/PDGFRβ at 11 days post injury with the lace like networks of cells, some of 
which show double labelling (arrows); B. Double labelling for MCM2 with PDGFRβ at 
13dpi confirms double labelled cells in perivascular location (arrowheads) in addition to 
MCM2/PDGFRβ- cells (arrow). C. MCM2/Olig2 at 9dpi and D. at 13dpi showing double 
labelled cell (arrowhead). E. Scatter graph of MCM2/Olig2 double-labelled cell density 
(/mm2) with dpi showing a significant declined in Zone 1 (p=0.028). F. Confocal images 
showing nestin-expressing cells grown from surgical temporal cortex of patients with focal 
epilepsy underwent cell division and incorporated EdU A, 24 hours after mechanical scratch 
injury. G. Quantification showed that more dividing cells were noted further away from the 
scratch. Scale bar in C is 60 microns in A-D; scale bar in F is 100um, and scale bar in (blue 
channel) is 20um. 
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Figure 5. Functional astrocytic markers Cx43, Aq4 and GS in ICR injuries 
A-F. Connexin 43 (Cx43): A. Low power of an ICR lesion involving the superficial cortex 
with a defined loss of labelling demarcating injury (asterisk) from adjacent parenchyma. B. 
Within the injury, labelling of endothelium as well as bipolar cells (arrowhead) is noted at 30 
dpi. C. The injury margin at 70dpi shows increased labelling in reactive cells and processes 
and D. Plump reactive cells are noted. E. In chronic lesions (264 dpi) intense labelling of 
cells and processes at the scar site is noted. F. Control region (Zone 3) with delicate, diffuse 
labelling of astrocytic processes. G. Scatter graphs of Cx43 labelling index with days post 
injury (shown as log) with a significant increase shown for the lesion core (p=0.03). H-J 
Aquaporin 4 (Aq4): H. ICR injury at low magnification with loss of labelling in lesion core 
(asterisk). I. In the margins at 8 dpi intense labelling of processes is noted. J. Control region 
with extensive labelling of glial processes. K-M Glutamine synthetase (GS): K. Reactive 
appearing GS positive cells in margin of injury at 13 dpi and L. intensely positive cells at 417 
dpi. M. In control region (Zone 3) labelling of astrocytic cells was shown. Scale bar 
equivalent to 500 microns in A and H and 50 microns in other figures.  
 
Figure 6. Cx43 labelling in glial cell types in intracranial recording lesions (ICR).  
Staining patterns in different stages of repair all in Zone 1 (margin of the ICR lesion): acute 8 
days post injury (dpi) (A-C), subacute 11dpi (D-F), intermediate 30 dpi (G-I) and chronic 
417 dpi (J-L). Nestin/Cx43: A. In acute lesions, peripheral Cx43 labelling was noted around 
large reactive nestin-expressing cells (arrowhead) with focal co-localisation in processes 
(arrow) (Split channel shown in Supplemental Figure 3F). D. In subacute lesions more 
prominent focal co-localisation in endothelium and perivascular cells was noted; this was still 
evident in elongated process in intermediate-age ICR lesions (arrowhead) although some 
large Cx43-positive cells were negative for nestin (chevron) G.  J. In chronic lesions co-
expression was noted in a proportion (but not all) nestin cells at the scar site. GFAP/Cx43: B. 
In acute lesions, marginal expression of Cx43 was noted around large reactive GFAP+ cells 
(arrow) as well as co-localisation in some processes (arrowhead) (Split channel shown in 
Supplemental Figure 3E). E. In subacute and H. intermediate lesions, co-labelling of 
processes was noted (arrowheads) although many large Cx43-positive reactive appearing 
cells (chevron) were negative for GFAP. K. In chronic lesions, a more general overlap 
between the meshwork of glia fibres in the scar and Cx34 was observed. PDGFRβ/Cx43: C. 
In acute lesions there were many Cx43 processes that were not PDGFRβ-positive. F. In 
subacute lesions some co-localisation was noted in pericyte like cells around capillaries 
(arrowhead; shown in split channels in Supplemental figure 3D). I. In intermediate lesions, 
lack of co-labelling is appreciated between large reactive Cx43+ cells (chevron) cells and foot 
processes around capillary pericytes and in L. this was also appreciated in chronic lesions. 
Control Zone 3: M Extensive labelling is noted with Cx43 in the cortex however a 
proportion of GFAP astrocytic domains are devoid of Cx43 labelling. N. Patchy or non-
confluent labelling with Cx43 is noted and separate from the PDGFRβ in capillaries; (inset) 
occasional multipolar cell shows co-localisation. O. Linear regression analysis for the 
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relationship between co-localisation of the three markers (GFAP, Nestin, or PDGFRβ) and 
Cx43 with dpi (expressed as Log10); there was a statistically significant increase noted for 
GFAP and nestin with chronicity of injury. Scale bar in M is equivalent to 20 microns in A-J, 
100 microns in K-N. 
 
Supplemental Figure 1. Immunofluorescence images shown as split channels in green 
and purple.  
A. PDGFRβ/NESTIN in subacute injury lesion in zone 1 (from Figure 2D) and B (from 
Figure 2E); arrow is single labelled endothelial cell with nestin and arrowheads indicate 
double labelled perivascular cell. C. PDGFRβ/NESTIN in intermediate injury in zone 1 
showing overlap of labelling in reactive cells at injury margin (from figure 2F). C’ From 
figures 2J to L with cellular detail at higher magnification. D. PDGFRβ/Cx43 in 
subacute lesion (from Figure 6F) showing Cx43 labelling in endothelium and focal co-
labelling in pericyte cells (arrowheads). E. Cx43/GFAP in acute injury in marginal Zone 1 
showing co-expression in some processes and peripheral labelling of Cx43 of some reactive 
large glial cells (arrowhead) (from Figure 6B). F Cx43/Nestin in acute injury in marginal 
Zone 1 showing co-expression in some processes and peripheral labelling of Cx43 of some 
reactive large glial cells (arrowhead) (from Figure 6A). 
 
Supplemental Figure 2. Nestin, PDGFRβ and GFAP labelling with injury age  
A. Scatter graphs of labelling index of nestin, PDGFRβ and GFAP plotted against dpi 
(expressed as log10) for zone 3 with no significant regressions.  
B. Graphical representation of the relative area of co-localisation between GFAP or nestin 
with PDGFRβ at different stages of injury; both showing significant differences for all cases 
between Zone 1 and 3 but only nestin showing significant difference at the subacute stage. 
 
Supplemental Figure 3. Summary schematic illustrating the expression of different 
proliferative cell types around the lesion at various intervals post injury. This is based on 
the data in current and previous study [5].  The height of the bar refers to level of expression 
or numbers of dividing cell types. Immediately after injury, the number of dividing Iba1+ 
microglia and nestin+ expressing cells are upregulated around the lesion, reaching maximal 
numbers around two weeks post lesion. At two weeks, an increased number of dividing 
PDGFRβ+ and Olig2+ expressing cells were also observed around the lesion. After a month 
post lesion, the number of Iba+ microglia, and Olig2+ oligodendrocytes decreased 
dramatically, reaching similar number of cells found in Zone 3 (normal level). In contrast, 
many dividing GFAP+ astroglia were observed only after one month after injury.  A higher 
number of MCM2+/GFAP+ cells were still found around lesion after four months post lesion, 
together with few nestin+ and PDGFRβ+ cells. The level of co-expression between 
PDGFRβ+ and nestin (red bars within nestin+) were maximally observed a week after post 
and gradually decrease with time. In contrast, the PDGFRβ+ and GFAP was maximally 
observed two months after lesion. The expression of CX43 was significantly reduced from 
normal level, immediately following injury, but increased after a month, coinciding with the 
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upregulation of GFAP. Some PDGFRβ+and nestin+ expressing cells in Zone 1 were found to 
express CX43 one month after lesion (Bar colours - Blue, Iba1; purple, nestin; yellow, GFAP; 
red, PDGFRbeta; brown, olig2 and grey, Cx43). 
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